Concerns over China’s growing export strength have intensified in Europe and the United States, where critics argue that Chinese overproduction is undermining Western manufacturing and posing broader economic and security challenges. However, experts suggest that this export surge is largely an unintended consequence of China’s pursuit of self-sufficiency and competitiveness, rather than a deliberate strategy to dominate global markets through subsidies.
China’s rise as a major exporter includes significant advances beyond low-cost consumer goods, extending into high-technology sectors such as electric vehicles, robotics, high-speed rail, and artificial intelligence. Additionally, China holds a dominant position in critical industries like rare earth elements, essential for numerous green and digital technologies. This diversification has raised alarms about threats not only to jobs but also to national pride and security in Western countries.
Beyond these well-known sectors, China has also become a leading force in pharmaceuticals, biotechnology, and advanced materials. Chinese chemists produce over 60 percent of the world’s citric acid, a key food additive, along with a substantial share of sweeteners, thickeners, and preservatives. The country contributes about 30 percent of global novel drug development and supplies 41 percent of the key starting materials for pharmaceuticals approved in the U.S. China’s prominence in biotechnology is notable in targeted cancer therapies and ongoing research addressing diabetes and obesity, driven mainly by domestic public health needs.
An illustrative example of China’s expansive scientific resources is its former role as the world’s largest exporter of laboratory monkeys used in U.S. biomedical research. The suspension of these exports due to the COVID-19 pandemic has impacted American pharmaceutical studies by increasing costs and limiting research animals. Meanwhile, China has expanded its own medical research capabilities and now leads in exporting advanced medical therapies.
China’s export success stems from domestic policies aimed at fostering self-reliance, supported by a vast consumer market and a large skilled workforce that includes over 1.3 million engineering graduates annually—vastly surpassing the United States. While other manufacturing powerhouses such as Japan, Germany, and South Korea have also promoted industrial competitiveness, none possess China’s scale of domestic consumers or workforce.
The debate over Chinese overproduction is further complicated by the role of targeted subsidies within China’s industrial strategy. These subsidies are typically time-limited and focused on boosting domestic economic development rather than direct export promotion. As a result, increased Chinese exports are often a by-product of rising domestic production capacity meeting internal demand.
Comparing production and export volumes in the automotive sector illustrates the complexities of labeling China as an “overproducer.” For instance, China’s BYD manufactured 4.6 million electric vehicles last year, exporting about 23 percent, while Germany exported over 76 percent of its 4.15 million vehicles, and Toyota in Japan sold only about 14 percent of its 10.5 million cars domestically.
Experts caution that while protectionist measures may provide short-term relief for industries challenged by Chinese competition, they do not address the underlying structural shifts driving global trade dynamics. Sustainable responses will require more comprehensive strategies beyond imposing tariffs or other immediate trade barriers.